Search - tctmd.com

Displaying 341 - 360 of 1203

Sort: Relevancy | Date

Presentation TCT 2015

Scotland Presents: A Case of Bioresorbable Vascular Scaffold for Acute Plaque Rupture

Presenter: Graham A. Cassel, Nick Curzen, Niall T. Mulvihill, Margaret B. McEntegart

October 12, 2015

Presentation TCT 2015

South Africa Presents: How Did I Treat This Case?

Presenter: Graham A. Cassel, Nick Curzen, Niall T. Mulvihill, Chris Andrew Zambakides

October 12, 2015

Presentation TCT 2015

South Africa Presents: A Case of Double Acute Occlusion Which Vessel to Open and When

Presenter: Graham A. Cassel, Nick Curzen, Niall T. Mulvihill, Chris Andrew Zambakides

October 12, 2015

Presentation TCT 2015

UK Presents: Nonculprit Vessel Disease in STEMI

Presenter: Graham A. Cassel, Nick Curzen, Niall T. Mulvihill

October 12, 2015

Presentation TCT 2015

Introduction

Presenter: Graham A. Cassel, Nick Curzen, Niall T. Mulvihill

October 12, 2015

Presentation TCT 2015

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes

Presenter: Ioanna Kosmidou, Bernard R. Chevalier

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Ioanna Kosmidou, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Ioanna Kosmidou, Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

CENTURY II: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Two-Year Outcomes

Presenter: Spencer B. King III, Jagat Narula, Shigeru Saito

October 12, 2015

Presentation TCT 2015

PROMISE FFR-CT: Evaluation of FFR-CT in Patients Undergoing Computed Tomographic Angiography for Evaluation of Suspected Coronary Artery Disease

Presenter: Spencer B. King III, Jagat Narula, Michael Lu

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Gregg W. Stone, Ron Waksman, Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

Italy Presents: A Case Demonstrating the Diagnostic Workup in Nonobstructive Coronary Artery Disease

Presenter: Morton J. Kern, Jan J. Piek, Giampaolo Niccoli

October 12, 2015

News Conference News TCT 2015

Robotic Systems to Play Greater Role in Cath Lab of the Future

Todd Neale

October 12, 2015

News Conference News TCT 2015

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Yael L. Maxwell

October 12, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Industry News

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

October 12, 2015

Presentation TCT 2015

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Bernard Chevalier

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

Advertisement

Scotland Presents: A Case of Bioresorbable Vascular Scaffold for Acute Plaque Rupture

South Africa Presents: How Did I Treat This Case?

South Africa Presents: A Case of Double Acute Occlusion Which Vessel to Open and When

UK Presents: Nonculprit Vessel Disease in STEMI

Introduction

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease - Two-Year Outcomes

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Vs. an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

CENTURY II: A Prospective Randomized Trial of a Bioabsorbable-Polymer Biolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease Two-Year Outcomes

PROMISE FFR-CT: Evaluation of FFR-CT in Patients Undergoing Computed Tomographic Angiography for Evaluation of Suspected Coronary Artery Disease

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Italy Presents: A Case Demonstrating the Diagnostic Workup in Nonobstructive Coronary Artery Disease

Robotic Systems to Play Greater Role in Cath Lab of the Future

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Two-Year Data From The First Randomized Comparison Between Bioresorbable Vascular Scaffolds and Everolimus-Eluting Metallic Stents Show Comparable Patient Outcomes

ABSORB II: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Absorb BVS Matches Xience V in Chinese Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content